Jack Schuler - May 21, 2024 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
Director, 10%+ Owner
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Jack Schuler
Stock symbol
BDSX
Transactions as of
May 21, 2024
Transactions value $
$0
Form type
4
Date filed
5/23/2024, 07:14 PM
Previous filing
May 21, 2024
Next filing
May 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSX Common Stock Options Exercise +87K +0.28% 30.8M May 23, 2024 By Jack W. Schuler Living Trust F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Award $0 +46.7K $0.00 46.7K May 21, 2024 Common Stock 46.7K Direct F3, F4, F5
transaction BDSX Stock Options (Right to Buy) Award $0 +37.1K $0.00 37.1K May 21, 2024 Common Stock 37.1K $1.57 Direct F6
transaction BDSX Series A Non-Voting Convertible Preferred Stock Options Exercise $0 -2.17K -100% $0.00* 0 May 23, 2024 Common Stock 87K By Jack W. Schuler Living Trust F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024.
F2 Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.
F3 Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Common Stock.
F4 These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.
F5 Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer.
F6 This option will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, this option will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.